For educational purposes and social benefit, not for profit. 

The Mission of the Outbreak Response International Open Network™ (ORION) is to end viral outbreaks before they can proliferate into epidemics or pandemic.

The Coalition for Epidemic Preparedness Innovation (CEPI) was launched at Davos 2017 by Norway, Wellcome Trust, The Bill and Melinda Gates Foundation,, Germany and Japan.

Since participating in the CEPI launch at Davos 2017, eCAM Biomed Global Impact Fund has been in development of the public-private Vaccine Bond impact investment model.

The resulting product by eCAM Biomed Global Impact Fund:

  1. ECAM-V Fixed Income Vaccine Bond. The ORION Vaccine Bond to be leveraged by the ECAM-R private equity fund for competitive financial performance and extraordinary impact.
  2. The Outbreak Response Open International Network (ORION), to be supported pro bono, by investors in eCAM Biomed Global Impact Fund.

Not an Offer to Invest.

Accredited Investors and Qualified Institutional Buyers Only.

Please See Red Herring Disclosure and Private Placement Memorandum.

eCAM Biomed Global Impact Private Equity Fund – GFSC reference 2566471

eCAM Biomed Global Impact Investment Management Limited – GFSC reference 2566474

eCAM Biomed Global Impact Limited – FCA Reference number: 926731